MedicineNet.com
About Us | Privacy Policy | Site Map
January 7, 2009
  MedicineNet home Picture Slideshows Diseases and conditions Symptoms and signs Procedures and tests Medications Health and Living Health news and views MedTerms medical dictionary  
Font Size
A
A
A


Medication Written by Pharmacists Reviewed by Doctors

Pharmacy Author: Omudhome Ogbru, Pharm.D.
Medical Editor: Jay Marks, M.D.

GENERIC NAME: leflunomide

BRAND NAME: Arava

DRUG CLASS AND MECHANISM: Leflunomide is an oral, disease-modifying drug that is used in the treatment of rheumatoid arthritis. Leflunomide reduces inflammation in the joints that is responsible for both the symptoms of rheumatoid arthritis and the destruction of joints. This reduces symptoms as well as the progressive deformities of the joints caused by the arthritis. Leflunomide reduces inflammation by suppressing the activity of immune cells responsible for the inflammation. Leflunomide suppresses immune cells by inhibiting dihydroorotate dehydrogenase, an enzyme that is necessary for the production of DNA and RNA. Without DNA and RNA the immune cells (and most other types of cells) cannot multiply or function (or exist). Because of its unique and different mechanism of action, leflunomide is of value when added to other medications used for treating rheumatoid arthritis. Leflunomide was approved by the FDA in September, 1998.

PRESCRIPTION: Yes

GENERIC AVAILABLE: No

PREPARATIONS: 10, 20, and 100 mg tablets

STORAGE: Leflunomide should be stored at room temperature 15-30°C (59-86°F).

PRESCRIBED FOR: Leflunomide is used for the treatment of active rheumatoid arthritis in adults. It reduces the signs, symptoms and joint damage caused by rheumatoid arthritis.

DOSING: The usual dose is 100 mg daily for the first 3 days, followed by 20 mg daily. Doctors may reduce the dose to 10 mg daily if side effects appear. It may require up to four weeks of therapy before improvement of the arthritis are seen. It is not known if ingestion of food or alcohol affects the absorption or action of leflunomide.

DRUG INTERACTIONS: Cholestyramine and charcoal decrease the concentration of the active form of leflunomide in the blood probably by preventing absorption. Rifampin increases the blood concentration of the active form of leflunomide by 40% probably by increasing the conversion of leflunomide to its active form. This may increase the side effects of leflunomide.

PREGNANCY: Leflunomide is harmful to the developing fetus and should not be used during pregnancy.

NURSING MOTHERS: It is unknown whether leflunomide accumulates in breast milk. Since leflunomide could cause harm to the infant, women taking leflunomide should probably refrain from breastfeeding.

SIDE EFFECTS: The most frequently reported side effects are diarrhea, nausea, headache, rash, itching, loss or thinning of hair and weight loss. Leflunomide also may cause high blood pressure, chest pain and abnormal heartbeats. Since leflunomide suppresses the immune system, it may increase the risk to patients of infections. The most frequently reported infections involve the respiratory tract. Leflunomide may cause abnormal liver tests in the blood, suggesting damage to the liver. The liver tests usually return to normal with continued treatment. The dose of leflunomide should be reduced if liver tests are persistently greater than twice the upper limit of normal, and leflunomide should be discontinued if the levels remain above three times the upper limit of normal despite a reduction in dose. Leflunomide should not be administered to individuals with liver problems.


Last Editorial Review: 4/10/2003




Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Printer-Friendly Format  |  Email to a Friend


space Related health and medical articles From the Doctors at MedicineNet.com MedicineNet Doctors recommend space
space
MedicineNet Doctors Recommend
  • Rheumatoid Arthritis - Learn more about rheumatoid arthritis, an autoimmune disease that causes chronic joint inflammation, which has symptoms that include stiffness, fever, muscle and joint aches, loss of appetite, and fatigue. Treatment of rheumatoid arthritis incorporates the use of first-line drugs (aspirin and corticosteroids for pain and inflammation) and second-line drugs (methotrexate and hydroxychloroquine to prevent joint destruction and promote remission). Source:MedicineNet
  • Ankylosing Spondylitis - Read about ankylosing spondylitis (a form of chronic inflammation of the spine and the sacroiliac joints), which causes spinal pain and stiffness. As ankylosing spondylitis is a systemic rheumatic disease, it may also affect joints and organs. Ankylosing spondylitis symptoms include fatigue and pain and stiffness in the low back, upper buttocks, neck, and spine regions, which is typically worse in the mornings. Aspirin, NSAIDs, and TNF blockers may be necessary for treatment of ankylosing spondylitis. Source:MedicineNet
  • Psoriatic Arthritis - Learn more about psoriatic arthritis, including a description, causes, symptoms, diagnosis, treatment, medications and future outlook. Source:MedicineNet
  • Read 28 more leflunomide related articles ...
Latest Medical News
space

Back to Medications Index

Arthritis

Get the latest treatment options




Symptoms & Signs A-Z List Pinpoint Your Symptoms - Start Now Symptoms & Signs A-Z List Symptoms & Signs by Female Body Region Symptoms & Signs by Male Body Region

Topics Related to leflunomide, Arava


leflunomide
RSS FeedSpecialty RSS       Add to My Yahoo! What is this?

Joint CampJoint Camp
Today, Baby Boomers go to "joint" camp to prepare for hip and knee replacement surgery. See more WebMD Videos »












Health categories:

Slideshows | Diseases & Conditions | Symptoms & Signs | Procedures & Tests | Medications | Health & Living | News & Views | Medical Dictionary

Popular health centers:

Allergies | Arthritis | Cancer | Diabetes | Digestion | Healthy Kids | Heart | Men's Health | Mental Health | Women's Health | More...

Publications:

ePublications (PDFs) | XML News via RSS | Audio Podcasts | Email Newsletters

MedicineNet.com:

About Us | Privacy Policy | Search Help | Site Map | WebMD® | Medscape® | eMedicine® | eMedicineHealth® | RxList®

HON Code We comply with the HONcode standard for health trust worthy information:
verify here.

©1996-2009 MedicineNet, Inc. All rights reserved. Notices and Legal Disclaimer.
MedicineNet does not provide medical advice, diagnosis or treatment. See additional information.